Risk of Melanoma with Psoralen/Ultraviolet A Therapy for Psoriasis: Do the Known Risks Now Outweigh the Benefits?
- Published in:
- Drug Safety, 1999, v. 20, n. 4, p. 289
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 1999 AND VI 20 AND IP 4
Results: 6
1
2
A Risk-Benefit Assessment of HIV Protease Inhibitors.
- Published in:
- Drug Safety, 1999, v. 20, n. 4, p. 299, doi. 10.2165/00002018-199920040-00002
- By:
- Publication type:
- Article
3
A Risk-Benefit Assessment of Oxytocics in Obstetric Practice.
- Published in:
- Drug Safety, 1999, v. 20, n. 4, p. 323, doi. 10.2165/00002018-199920040-00003
- By:
- Publication type:
- Article
4
Drugs Hazardous to Healthcare Workers: Evaluation of Methods for Monitoring Occupational Exposure to Cytostatic Drugs.
- Published in:
- Drug Safety, 1999, v. 20, n. 4, p. 347, doi. 10.2165/00002018-199920040-00004
- By:
- Publication type:
- Article
5
Treating Allergic Rhinitis in Pregnancy: Safety Considerations.
- Published in:
- Drug Safety, 1999, v. 20, n. 4, p. 361, doi. 10.2165/00002018-199920040-00005
- By:
- Publication type:
- Article
6
Lactic Acidosis in Metformin-Treated Patients: Prognostic Value of Arterial Lactate Levels and Plasma Metformin Concentrations.
- Published in:
- Drug Safety, 1999, v. 20, n. 4, p. 377, doi. 10.2165/00002018-199920040-00006
- By:
- Publication type:
- Article